← Back to Search

Diet and Exercise for Breast Cancer (DREAM Trial)

N/A
Waitlist Available
Led By Richard Thompson, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Starting (or having only received one treatment of) any type of intravenously administered chemotherapy
Diagnosis of stage IV or metastatic breast cancer
Must not have
History of eating disorder (diagnosed or self-reported)
Unable to provide informed consent (i.e. cognitive impairment)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-6 weeks before the first chemotherapy treatment of the first cycle and 1-3 weeks after the last chemotherapy treatment of the third cycle
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether an intervention of aerobic exercise and caloric restriction can improve outcomes for people with metastatic breast cancer.

Who is the study for?
This trial is for adults over 18 with stage IV or metastatic breast cancer who are starting or have had one chemotherapy treatment. Participants must be able to perform some exercise, follow a special diet, and not have severe kidney issues, diabetes, extreme weight loss, strict dietary restrictions like veganism, or any condition that would limit exercise like bone metastases.
What is being tested?
The study tests if a combination of aerobic exercise during chemo infusions and a low-carb diet before each treatment can improve outcomes in metastatic breast cancer patients. Fifty participants will either receive this intervention alongside their regular chemo or just the usual care without these additions.
What are the potential side effects?
Potential side effects may include fatigue from the exercise regimen and possible nutritional deficiencies due to caloric restriction. The impact on quality of life and symptoms will be monitored through questionnaires.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am starting or have had only one round of chemotherapy given through my veins.
Select...
My breast cancer has spread to other parts of my body.
Select...
My cancer has spread and can be measured.
Select...
I am older than 18 years.
Select...
I can take care of myself but might not be able to do heavy physical work.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of an eating disorder.
Select...
I am able to understand and agree to the study's procedures and risks.
Select...
I need extra oxygen.
Select...
I weigh more than 109 kg.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-6 weeks before the first chemotherapy treatment of the first cycle and 1-4 weeks after the last chemotherapy treatment of the last cycle
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-6 weeks before the first chemotherapy treatment of the first cycle and 1-4 weeks after the last chemotherapy treatment of the last cycle for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Tumor size change after 6 cycles (mm)
Secondary study objectives
Tumor response to therapy by magnetic resonance imaging (mm²/s)
Tumor size change after 3 cycles (mm)
Other study objectives
Fatigue
Left ventricular ejection fraction (%)
Left ventricular global longitudinal strain (%)
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Standard chemotherapy treatment and oncology care plus short-term diet and exercise intervention.
Group II: Control GroupActive Control1 Intervention
Standard chemotherapy treatment and oncology care.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
939 Previous Clinical Trials
433,890 Total Patients Enrolled
14 Trials studying Breast Cancer
2,598 Patients Enrolled for Breast Cancer
Canadian Cancer Society (CCS)OTHER
81 Previous Clinical Trials
41,392 Total Patients Enrolled
6 Trials studying Breast Cancer
508 Patients Enrolled for Breast Cancer
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,518,050 Total Patients Enrolled
10 Trials studying Breast Cancer
4,707 Patients Enrolled for Breast Cancer

Media Library

Short-term diet and exercise intervention Clinical Trial Eligibility Overview. Trial Name: NCT03795493 — N/A
Breast Cancer Research Study Groups: Intervention Group, Control Group
Breast Cancer Clinical Trial 2023: Short-term diet and exercise intervention Highlights & Side Effects. Trial Name: NCT03795493 — N/A
Short-term diet and exercise intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03795493 — N/A
~4 spots leftby Nov 2025